Biotechnology and Pharmaceutical Services Outsourcing Market Size, Share, and Trends 2024 to 2034

The global biotechnology and pharmaceutical services outsourcing market size is calculated at USD 51.53 billion in 2025 and is forecasted to reach around USD 85.74 billion by 2034, accelerating at a CAGR of 5.82% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 1483
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biotechnology and Pharmaceutical Services Outsourcing Market 

5.1. COVID-19 Landscape: Biotechnology and Pharmaceutical Services Outsourcing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biotechnology and Pharmaceutical Services Outsourcing Market, By Services

8.1. Biotechnology and Pharmaceutical Services Outsourcing Market, by Services Type,

8.1.1. Consulting

8.1.1.1. Market Revenue and Forecast

8.1.2. Auditing and Assessment

8.1.2.1. Market Revenue and Forecast

8.1.3. Regulatory Affairs

8.1.3.1. Market Revenue and Forecast

8.1.4. Others

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Biotechnology and Pharmaceutical Services Outsourcing Market, By Services Outsourcing

9.1. Biotechnology and Pharmaceutical Services Outsourcing Market, by Services Outsourcing,

9.1.1. Pharma

9.1.1.1. Market Revenue and Forecast

9.1.2. Biotech

9.1.2.1. Market Revenue and Forecast

Chapter 10. Global Biotechnology and Pharmaceutical Services Outsourcing Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Services

10.1.2. Market Revenue and Forecast, by Services Outsourcing

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Services

10.1.3.2. Market Revenue and Forecast, by Services Outsourcing

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Services

10.1.4.2. Market Revenue and Forecast, by Services Outsourcing

10.2. Europe

10.2.1. Market Revenue and Forecast, by Services

10.2.2. Market Revenue and Forecast, by Services Outsourcing

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Services

10.2.3.2. Market Revenue and Forecast, by Services Outsourcing

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Services

10.2.4.2. Market Revenue and Forecast, by Services Outsourcing

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Services

10.2.5.2. Market Revenue and Forecast, by Services Outsourcing

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Services

10.2.6.2. Market Revenue and Forecast, by Services Outsourcing

10.3. APAC

10.3.1. Market Revenue and Forecast, by Services

10.3.2. Market Revenue and Forecast, by Services Outsourcing

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Services

10.3.3.2. Market Revenue and Forecast, by Services Outsourcing

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Services

10.3.4.2. Market Revenue and Forecast, by Services Outsourcing

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Services

10.3.5.2. Market Revenue and Forecast, by Services Outsourcing

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Services

10.3.6.2. Market Revenue and Forecast, by Services Outsourcing

10.4. MEA

10.4.1. Market Revenue and Forecast, by Services

10.4.2. Market Revenue and Forecast, by Services Outsourcing

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Services

10.4.3.2. Market Revenue and Forecast, by Services Outsourcing

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Services

10.4.4.2. Market Revenue and Forecast, by Services Outsourcing

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Services

10.4.5.2. Market Revenue and Forecast, by Services Outsourcing

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Services

10.4.6.2. Market Revenue and Forecast, by Services Outsourcing

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Services

10.5.2. Market Revenue and Forecast, by Services Outsourcing

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Services

10.5.3.2. Market Revenue and Forecast, by Services Outsourcing

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Services

10.5.4.2. Market Revenue and Forecast, by Services Outsourcing

Chapter 11. Company Profiles

11.1. ICON Plc

11.1.1. Company Overview

11.1.2. Product Offering

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. The Quantic Group

11.2.1. Company Overview

11.2.2. Product Offering

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Covance Inc.

11.3.1. Company Overview

11.3.2. Product Offering

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. PFA Health Sciences

11.4.1. Company Overview

11.4.2. Product Offering

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. IQVIA Holdings Inc.

11.5.1. Company Overview

11.5.2. Product Offering

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Lachman Consultant Services

11.6.1. Company Overview

11.6.2. Product Offering

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Charles River

11.7.1. Company Overview

11.7.2. Product Offering

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Parexel International Corporation

11.8.1. Company Overview

11.8.2. Product Offering

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. GMP Pharmaceuticals

11.9.1. Company Overview

11.9.2. Product Offering

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Concept Heidelberg GmbH

11.10.1. Company Overview

11.10.2. Product Offering

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Precedence Research Predict, the global biotechnology and pharmaceutical services outsourcing market size was reached at USD 48.70 billion in 2024 and is projected to surpass USD 85.74 billion by 2034.

The global biotechnology and pharmaceutical services outsourcing market is growing at a CAGR of 5.82% from 2025 to 2034.

The biotechnology and pharmaceutical services outsourcing market is likely to be driven by rising price competition, a lack of internal capabilities, low-cost service offers Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs), and access to industry experts.

Some of the prominent players in the global biotechnology and pharmaceutical services outsourcing market such as ICON Plc, The Quantic Group, Covance Inc., PFA Health Sciences, IQVIA Holdings Inc., Lachman Consultant Services, Charles River, Parexel International Corporation, GMP Pharmaceuticals, Concept Heidelberg GmbH.

Asia Pacific is the largest segment for biotechnology and pharmaceutical services outsourcing market in terms of region.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client